CN
Healthcare/Pharma Companies
  • Zhejiang Guobang Pharmaceutical Co., Ltd Zhejiang Guobang Pharmaceutical Co., Ltd. is a wholly foreign owned enterprise located in Hangzhou Bay Shangyu Economic & Development Area(HSEDA), Zhejiang Province and situated in the very center...
  • Zhejiang Guobang Pharmaceutical Co., Ltd

    Zhejiang Guobang Pharmaceutical Co., Ltd. is a wholly foreign owned enterprise located in Hangzhou Bay Shangyu Economic & Development Area(HSEDA), Zhejiang Province and situated in the very center of the train line connecting Hangzhou and Ningbo.
     
    As a hi-tech enterprise at provincial level, the company has a post-doctoral research station and a technology center. The company is a major manufacturer of such synthesis drug materials as Azithromycin, Clarithromycin, Roxithromycin, Ciprofloxacin and Deoxifluorine. As the largest supplier of Enrofloxacin in the world, the company also enjoys great reputation throughout the whole country in terms of veterinary drug materials. All products pass GMP certification conducted by State Food and Drug Administration and Ministry of Agriculture of PRC. In addition, the company has gradually implemented COD and FDA certifications in accordance with customers' requirements. Implementation of safety DCS and multiple environmental measures are widely recognized in the sector.
     
    Covering an area of 175,000 square meters, the company has more than 10 workshops of bulk drugs at different sizes. The company actively enlarges the supply to international counterparties, and strives to promote cooperation mode that develops approved products together with domestic formulation enterprises. Zhejiang Guobang Pharmaceutical Co.,Ltd. is a very professional supplier of bulk drugs with global reputation.
    Homepage: www.gbpharm.com

  • Zhejiang NHU Co., Ltd Established in 1999 with headquarter in Xinchang Zhejiang Province.  Zhejiang NHU Co.,Ltd specializes in the production of bulk pharmaceutical chemicals, medications, health products, food additi...
  • Zhejiang NHU Co., Ltd

    Established in 1999 with headquarter in Xinchang Zhejiang Province.  Zhejiang NHU Co.,Ltd specializes in the production of bulk pharmaceutical chemicals, medications, health products, food additives, feed additives, flavors and aromas and it has modern production bases in Xinchang, Meizhu, Shangyu and Shandong. In 2004, NHU was listed as the first enterprise in Small-and Medium-sized Enterprises Board in Shenzhen with the stock code of 002001.
    NHU has a state-level technology center, a National Postdoctoral Research &Development Center, and has developed 14 state-level new products,13 National Torch Plan Projects, 1 National Key Technology Research & Development Program, 2 National Science and Technology Support Programs, 2 National High Technology Research & Development Program of China (863 Program) and obtained 64 patent licenses. NHU is a Chinese Famous Trademark, and Vitamin feed branded NHU is a Chinese Famous Product. In 2011, the new green synthesis process and industrialization of soluble Vitamins and carotenoid achieved the second prize of the National Science and Technology Invention Award.
    NHU will adhere to the professional way, focus in the field of fine chemicals, strengthen the major, strive for the aim of “Innovating Fine Chemical Technology, Improving the Quality of Human Life”, and make NHU become an international famous multinational fine chemical enterprise.

    Shangyu production base, located in Hangzhou Bay Shangyu Economic Development Area, covering an area of 666,000 square meters, with 3 billion yuan of total investment. The company has three enterprises, Shangyu NHU Bio-Chem Co.,Ltd., Zhejiang NHU Pharmaceutical Co.,Ltd., and Zhejiang NHU Construction Material Co., Ltd.. Main products are vitamin A (E), carotenoids, PPS and other special engineering plastics.
    The Shangyu production base is performing TPM management and sustainable development of environmental protection. Established a research and innovation center, it makesbreakthroughs of key technologies in organic synthesis and bio-fermentation. It implemented several national Torch Program and 863 Projects, to create a world-class manufacturing base of fine chemical products.
    Homepage: www.cnhu.com

  • Shangyu Nutrichem Co., Ltd Shangyu Nutrichem Co., Ltd., is the wholly owned subsidiary of Beijing Nutrichem Biological Technologies Inc, as the national pesticide production enterprise and key high-tech enterprise. The company,...
  • Shangyu Nutrichem Co., Ltd

    Shangyu Nutrichem Co., Ltd., is the wholly owned subsidiary of Beijing Nutrichem Biological Technologies Inc, as the national pesticide production enterprise and key high-tech enterprise. The company, founded in November 2003, is located in the Hangzhou Bay Shangyu Economic and Technological Development Zone (national level), with the registered capital of 180 million yuan, the total assets of 1 billion 200 million yuan. The company covers an area of 146000 square meters, the staff are more than 700 people, including all kinds of professional and technical personnel accounting for more than 30% of the total number of employees. It mainly produces over 20 technicals and formulations such as oxyfluorfen , metolachlor, tebuconazole, azoxystrobin, etc. The company has formed an annual output of 50 thousand tons of the scale of production of raw materials and formulations. The products include weeding agent, fungicide, insecticide, security agent, and the company has formed a long-term strategic partnership with the Dow, Bayer, Adaoma and other multinational companies. The company actively cooperates with the Zhejiang University of Technology and other well-known colleges and universities to carry out the construction of scientific research platform, project cooperation, joint training. The company has completed the provincial enterprise institute, Provincial Key Laboratory and academician expert workstation.

    Homepage: www.nutrichem.cn
  • Zhejiang Zhebang Pharmaceutical Co., Ltd Zhejiang Zhebang Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise with pharmaceutical APIs and intermediates as main products. Located in Shangyu Industrial Park of Hangzhou Bay i...
  • Zhejiang Zhebang Pharmaceutical Co., Ltd

    Zhejiang Zhebang Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise with pharmaceutical APIs and intermediates as main products. Located in Shangyu Industrial Park of Hangzhou Bay in the south wing of Yangtze River Delta (Shanghai is the central city of this region).The company has good location and convenient transportation to cities like Ningbo and Shanghai.

    As a famous China manufacturer for chemical synthetic APIs, theyare mainly engaged in the research, development, production and trade of pharmaceutical APIs and intermediates. Their main products are Cephalosporin APIs (cefradine, cefalexin and cefaclor, etc.). They annually produce more than 1,000 tons of cefradine, and have over 60% market share in China market. Also they sell other products such as isotretinoin, Acitretin, ambroxol hydrochloride, Agomelatine, aztreonam (crude), tirofiban and cefprozil, etc.
    Sticking to such idea of "Human-oriented, leading technology, social service", Zhebang aims to "get development by leading technologies" and "establish cooperative relationships with universities and research institutes". Through establishing closely cooperative relationships with Zhejiang University, China Pharmaceutical University and other large pharmaceutical enterprises of China, the company are working hard on the research, development and production of hi-tech products, and striving to put more and more creative products into the market. The company has developed new drugs since 2010, including Cardiovascular drugs, diabetes drugs, antidepressant drugs, antiepileptic drugs and anti-cancer drugs.
    Company homepage: www.zhechem.com



  • Zhejiang Jingxin Pharmaceutical Co., Ltd Zhejiang Jingxin Pharmaceutical Co., Ltd. is a listed pharmaceutical company, integrating R & D, manufacturing and marketing. It ranks top 100 of the chemical pharmaceutical enterprises in China. ...
  • Zhejiang Jingxin Pharmaceutical Co., Ltd

    Zhejiang Jingxin Pharmaceutical Co., Ltd. is a listed pharmaceutical company, integrating R & D, manufacturing and marketing. It ranks top 100 of the chemical pharmaceutical enterprises in China. At present, the company’s registered capital is 320 million CNY and total asset is 2.9 billion CNY. The company occupies more than 80 ha’s land and owning more than 2300 stuff and headquarters in both Xinchang and Hangzhou. Five manufacturing bases are now under function, namely, formulations in Xinchang, API & intermediate in Shangyu and Guangfeng, traditional Chinese medicine in Inner Mongolia and medical apparatus and instruments in Shenzhen. Moreover, a R&D center is located in Shanghai Zhangjiang High-Tec Park for advanced drug and API development.
    Jingxin attaches great importance to R&D. Besides having their own world-class infrastructure for R&D, they also work closely with reputed institutes and universities to reinforce the commitment to innovative products. Now they have 8 national key new products and assume 9 National Torch Plans.
    Their products contain drug and medical devices. The drug products covered from API to finished product. Jingxinare one of the biggest manufacturing bases for the APIs of quinolones and occupy a relatively large market share for the product named Ciprofloxacin Hydrochloride and the Levofloxacin Hydrochloride. The product has been distributed to the international market such as South-east of Asia, South Asia, Latin America and Europe, Levofloxacin ranks No. 1 in the sales all around the world. The formulations focus on cardiovascular, digestive and neurological, among which, Simvastatin Tablet is the first finished product exported to UK, giving the first step for the Chinese formulation exported to the high-end market. Rosuvastatin Calcium Tablets owns the largest market share in the similar domestic products.Beside chemical drugs, they also produce TCM and bio-medicine.The TCM “Kangfuxin Solution” won the Gold Prize of “Illness Bane” by Ministry of Health was praised as “ Miraculous Drug” by patients, digestive products Bacillus licheniformis capsules is the bio-medicine of the company.  Regarding the medical devices, it is concentrated on the medical display instruments currently, providing full series medical imaging display solution, covers almost all medical imaging application areas, including clinical review, diagnostic, consultation center, digitized surgical room and ultrasound, CT, MRI, DR, DSA, DSI, endoscope etc.
    On the one side, the company is developing through independent research and developmentorganizations, on the other side, Jingxin is growing via M&A to accelerate the developing pace. In domestic market, Jingxin acquired a TCM factory in Inner Mongolia in 2007, a bio-medicine company in Beijing in 2011, a comprehensive pharmaceutical company in Guangdong Province in 2013 and an advanced medical devices company in 2015; In overseas market, Jingxin set up a joint venture in UK in 2014, invested a medical device company in Israel in 2015, got the corporate control of a US pharmaceutical company in 2015.
    Taking the quality concept of “make our products, by our heart”, Jingxin is in the first group of passing the SFDA GMP of new version. Previously, Jingxin had been certified by the EU GMP in 2006 and successfully passed the 3-years term’s re-inspection. The last inspection was conducted in May 2015. The new constructed workshop with much larger capacity was certified. Afterwards, the company began the preparation of the US FDA inspection to broaden the market in near future.
    Homepage: www.jingxinpharm.com




  • YongNong BioSciences CO., LTD The main business of YONGNONG (YONON) is to provide high-quality agrochemical products through product development, production, registration, marketing and distribution. The company builds a complete ...
  • YongNong BioSciences CO., LTD

    The main business of YONGNONG (YONON) is to provide high-quality agrochemical products through product development, production, registration, marketing and distribution. The company builds a complete product chain through, where Glufosinate-ammonium plays a leading role with many other varieties manufactured simultaneously, including herbicides, insecticides and fungicides. The strategy of globalization and branding helps YONON meets worldwide customers’ demands with global operation network, high-quality products and value-added services.
    YONON has almost 1200 employees working in three manufacturing sites, one technique center, one international trade company and Taiwan branch. The fourth manufacturing site is currently under construction in Jiangsu Province. The company enjoys a continuous sale growth and turnover achieves USD170 million in 2013. 
    YONON is the world’s first generic company to develop and produce Glufosinate-ammonium. Through more than a decade of production, the company now has 2500MT annual production capability for Glufosinate-ammonium tech and has become the world leading Glufosinate-ammonium provider. 
    YONON constantly invests in pesticide registration to comply with regulatory requirements in developed markets and emerging markets. YONON supports clients with high quality data and expertise for registration in Canada, USA, Brazil, EU and other countries. The company also makes own registrations in Brazil, EU, Australia and Taiwan. One of the key products Picloram technical was approved by Brazilian authorities in 2011 as the first registrant from China mainland while key product Glufosinate-ammonium technical was approved by EU authorities in 2014.

    Homepage: www.yongnongbiosciences.com


  • Shaoxing Xingxin Chemical Co., Ltd Shaoxing Xingxin Chemical Co., Ltd. was founded in 2002 and covers an area of 60,000. Our company is located in the Hangzhou Bay Shangyu Economic and Technological Development Zone. We have superior g...
  • Shaoxing Xingxin Chemical Co., Ltd

    Shaoxing Xingxin Chemical Co., Ltd. was founded in 2002 and covers an area of 60,000. Our company is located in the Hangzhou Bay Shangyu Economic and Technological Development Zone. We have superior geographical and transportation condition.
    We have successfully developed sodium hydride, piperazine products and amine products production line. In addition we have advanced production technique and stable quality. By the solid cooperation with domestic famous universities and research institutes, we win high praise among wide customers. We strictly carry out ISO 9001 and ISO 14001 quality system standards.

    Homepage: www.xingxinchem.com


  • Zhejiang Zhongxin Chemicals Co., Ltd

    Zhejiang Zhongxin Chemicals Co., Ltd. is an enterprise of science and technical type specializing in the research, development and production of fine chemicals such as pharmaceutical intermediat...

  • Zhejiang Zhongxin Chemicals Co., Ltd

    Zhejiang Zhongxin Chemicals Co., Ltd. is an enterprise of science and technical type specializing in the research, development and production of fine chemicals such as pharmaceutical intermediates. Located in Zhejiang Hangzhou Bay Shangyu Industrial Park, Zhongxin now covers an area of 18667 SQM and has 350 employees, 110 of them have the college record of formal schooling and over, 68 are professional scientists and technicians, 12 have senior professional titles (including 6 doctors and masters), and 35 have medium professional titles. Moreover, there are 5 experts and scholars who studied abroad in their core team.
    According to the spirit of scientific development they are making generous investment into R&D to keep innovation upon their manufacturing processes and techniques. In 2005, their "Industrialization project of key intermediates of new type antibiotic fluoroquinolones" was listed into the items of "Innovation fund for technology based firms item" by The Ministry of Science and Technical; in the same year. The company was approved as "Hi-Tech enterprise" by The Provincial S&T Bureau of Zhejiang and The Municipal S&T Bureau of Shaoxing. Their "Fluorobenzoic acid derivatives project" was approved as "National torch program item" by The Ministry of Science and Technical in 2006, and the company became one of the "Top-100 powerful companies" and one of the "Top-50 powerful taxpayers" in Shangyu city. Our company was approved as "Key hi-tech company of national torch program item" by The Ministry of Science and Technical in 2007.
    Adopting the leading technologies, they now have the good ability to offer quality and stable products; their main products are key intermediates of anti-infective (quinolone), including fluorobenzoic acid derivatives, fluorochloroacetophenone, N-methyl piperazine, and so on. These products now are very famous in the market and are well sold in Germany, Japan and India, etc. Now, their three main products of fluorobenzoic acid derivatives were approved as "China national key new products " by The Ministry of Science and Technical. Up to now, theyhave got a lot of certificates, including ISO-9001 quality system, ISO-14000 environment protection system, and ISO-18000 security and clean production system.
    In cooperation with Shanghai Research Institute of Organic Chemistry, Chinese Academy of Sciences (CAS), the company established the joint Shangyu Zhongke Baiyun Fine Chemical R&D center Co., Ltd. at the end of 2004. As the R&D base of new products and environment-friendly techniques and innovative base for the transfer of technical achievements, this centre has 4,000sqm of R&D building, equipped with leading experimental and inspectional instruments, 3 pilot plants (1,200sqm) and several general-purpose apparatuses for pilot-scale experiment. Moreover, they are the executive body of "The specialized market of fine chemical in online technical market in Zhejiang Province" and "The S&T innovative service platform of environment-friendly fine chemical techniques in Shangyu in Zhejiang province"; through integrating the innovative elements, they have working hard to improve their innovative ability and striving for the sustainable & fast development of fine chemical industry in Zhejiang Province.
    Homepage: www.zxchemgroup.com


  • Zhejiang Menovo Pharmaceutical Co., Ltd Zhejiang Menovo Pharmaceuticals Co., Ltd, the second biggest manufacturer site of Ningbo Menovo Pharmaceuticals Group Co., Ltd, located in the Shangyu Industrial Park, Zhejiang Hangzhou Bay. It’s a hi...
  • Zhejiang Menovo Pharmaceutical Co., Ltd

    Zhejiang Menovo Pharmaceuticals Co., Ltd, the second biggest manufacturer site of Ningbo Menovo Pharmaceuticals Group Co., Ltd, located in the Shangyu Industrial Park, Zhejiang Hangzhou Bay. It’s a hi-tech enterprise supported by the state with the diversified operation model, advanced scientific and technological development, and intensive management. The company mainly produces pharmaceutical intermediates and APIs based on powerful research and development, test, manufacture and sales. The products involve in the digestive system, central nervous system, blood pressure, lipid regulation and other fields. The company was founded in 2005, with the total investment of more than $ 14.7 million, the fixed assets more than 8600 million RMB and the annual output value of 300 million RMB.
    The company has nearly 500 employees, including nearly 250 college graduates, covering nearly 50% of total employees. The company relies on universities and research institutions, focuses on technological innovation and transformation, adheres to the "people-oriented, scientific management, quality first, customer first" as its principles, encourages exploration and promotes enterprise on the scale and the brand. The company acquired the ISO9000 and ISO14001 certificates in 2004 and 2011 respectively and passed official GMP audit of Slovenia EU in October 2008.
    As China's leading company specialized in the production of new drug research, the company has owned advanced equipment and facilities. The company covers an area of 60,000 square meters, building area covers 30,000 square meters and the plants, more than 18,000 square meters. There are four standard pharmaceutical intermediates production workshops, five fine drying package API production plants, one large fine drying package production plant under construction, a small scale laboratory fully equipped, and an analysis test center which covers 1,000 square meters with configured specialized equipment such as high performance liquid chromatography, gas chromatography, ultraviolet spectrometer, infrared spectrometer, Malvern particle size analyzer.
    Homepage: www.menovopharm.com


  • Zhejiang Second Pharma Co., Ltd Zhejiang Second Pharma Co., Ltd. is a state-controlled enterprise, which belongs to Top 500 China Resources Group. The company was established in 2003 with registered capital of 80.42 Million RMB. The...
  • Zhejiang Second Pharma Co., Ltd

    Zhejiang Second Pharma Co., Ltd. is a state-controlled enterprise, which belongs to Top 500 China Resources Group. The company was established in 2003 with registered capital of 80.42 Million RMB. The company mainly manufactures chemical Active Pharmaceutical Ingredients(APIs), including Valsartan, Isoniazid, Nicotinamide, etc., which is one of the main manufacturers in China. And the products sold well to the United States, EU, Southeast Asia and over dozens of countries and areas. With advanced instruments, equipment and a good quality management system, it is identified as National High-tech Enterprise. The company will focus on the manufacture of distinctive APIs, to become a competitive and influential enterprise in the APIs industry, and to maximize shareholders’ value and employees’ value through constant innovation and development.

    Homepage: www.zjxsk.com